Achim Plum

ORCID: 0000-0003-1635-1633
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Connexins and lens biology
  • Epigenetics and DNA Methylation
  • Cancer-related gene regulation
  • RNA modifications and cancer
  • Antibiotic Resistance in Bacteria
  • Genomics and Phylogenetic Studies
  • Neonatal and fetal brain pathology
  • Advanced Breast Cancer Therapies
  • Genetic Syndromes and Imprinting
  • Breast Cancer Treatment Studies
  • Heat shock proteins research
  • Anesthesia and Neurotoxicity Research
  • Cancer Genomics and Diagnostics
  • Cardiovascular Effects of Exercise
  • RNA regulation and disease
  • Pancreatic function and diabetes
  • Evolution and Genetic Dynamics
  • Metabolism and Genetic Disorders
  • Bacterial Identification and Susceptibility Testing
  • Cancer Treatment and Pharmacology
  • Kruppel-like factors research
  • Biochemical effects in animals
  • Diabetes Treatment and Management
  • Mitochondrial Function and Pathology
  • Hearing, Cochlea, Tinnitus, Genetics

Epigenomics (Germany)
2005-2023

University Children's Hospital Tübingen
2023

Mount Sinai Hospital
2022

University of Toronto
2022

KU Leuven
2022

British Columbia Children's Hospital
2022

Hospital for Sick Children
2022

SickKids Foundation
2022

Europe Hospitals
2022

Curetis (Germany)
2016-2019

ABSTRACT In order to reveal the biological function(s) of gap-junction protein connexin 45 (Cx45), we generated Cx45-deficient mice with targeted replacement Cx45-coding region lacZ reporter gene. Heterozygous Cx45+/− showed strong expression gene in vascular and visceral smooth muscle cells. embryos exhibited striking abnormalities development died between embryonic day (E) 9.5 10.5. Differentiation positioning endothelial cells appeared be normal, but subsequent blood vessels revealed...

10.1242/dev.127.19.4179 article EN Development 2000-10-01

We have shown that DNA methylation of the PITX2 gene predicts risk distant recurrence in steroid hormone receptor-positive, node-negative breast cancer. Here, we present results from a multicenter study investigating whether and other candidate markers predict outcome node-positive, estrogen HER-2-negative cancer patients who received adjuvant anthracycline-based chemotherapy.Using microarray platform, analyzed regulatory regions 60 additional genes 241 specimens. Using Cox regression...

10.1158/1078-0432.ccr-08-0166 article EN Clinical Cancer Research 2008-12-31

To analyze the molecular basis of gap junctional communication in mouse retina, we examined expression pattern following 13 connexin (Cx) genes: Cx26, Cx30, Cx30.3, Cx31, Cx31.1, Cx32, Cx36, Cx37, Cx40, Cx43, Cx45, Cx46, and Cx50. By using reverse transcriptase-polymerase chain reactions with primer oligonucleotides to murine genes, detected mRNAs Retinae from heterozygous mice targeted replacement most Cx45 open reading frame by a lacZ reporter gene showed promoter activity somata ganglion...

10.1002/1096-9861(20000918)425:2<193::aid-cne3>3.0.co;2-n article EN The Journal of Comparative Neurology 2000-01-01

The objective of this study was to compare the pharmacokinetics and pharmacodynamics insulin aspart (IA), a rapidly acting analog, with those human soluble (regular) (HI) in animal models after s.c. i.v. dosing. Single doses IA HI were administered rats dogs at three dose levels, one level pigs; also underwent repeated dosing for 1 week. Plasma levels assessed predetermined time points dosing; plasma glucose measured pigs only. There no significant pharmacokinetic differences between single...

10.1016/s0090-9556(24)15122-7 article EN Drug Metabolism and Disposition 2000-02-01

High-throughput next-generation shotgun sequencing of pathogenic bacteria is growing in clinical relevance, especially for chromosomal DNA-based taxonomic identification and antibiotic resistance prediction. Genetic exchange facilitated extrachromosomal DNA, e.g. plasmid-borne genes. Consequently, accurate plasmids from whole-genome (WGS) data remains one the major challenges sequencing-based precision medicine infectious diseases. Here, we assess heterogeneity four state-of-the-art tools...

10.1093/bib/bbx162 article EN Briefings in Bioinformatics 2017-11-29

Emerging antibiotic resistance is a major global health threat. The analysis of nucleic acid sequences linked to susceptibility phenotypes facilitates the study genetic determinants inform molecular diagnostics and drug development. We collected data (11,087 newly-sequenced whole genomes) culture-based profiles (10,991 out 11,087 isolates comprehensively tested against 22 antibiotics in total) clinical including 18 main species spanning time period 30 years. Species specific patterns were...

10.1016/j.gpb.2018.11.002 article EN cc-by Genomics Proteomics & Bioinformatics 2019-04-01

Multidrug-resistant pathogens represent one of the biggest global healthcare challenges. Molecular diagnostics can guide effective antibiotics therapy but relies on validated, predictive biomarkers. Here we present a novel, universally applicable workflow for rapid identification antimicrobial resistance (AMR) biomarkers from clinical Escherichia coli isolates and quantitatively evaluate potential to recover causal observed phenotypes. For this, metagenomic plasmid library 1,110 E. was...

10.3389/fmicb.2019.01671 article EN cc-by Frontiers in Microbiology 2019-08-13

Whole-genome sequencing (WGS) is gaining importance in the analysis of bacterial cultures derived from patients with infectious diseases. Existing computational tools for WGS-based identification have, however, been evaluated on previously defined data relying thereby unwarily available taxonomic information.Here, we newly sequenced 846 clinical gram-negative isolates representing multiple distinct genera and compared performance five (CLARK, Kaiju, Kraken, DIAMOND/MEGAN TUIT). To establish...

10.1093/bib/bbw122 article EN Briefings in Bioinformatics 2016-11-07

To analyze the molecular basis of gap junctional communication in mouse retina, we examined expression pattern following 13 connexin (Cx) genes: Cx26, Cx30, Cx30.3, Cx31, Cx31.1, Cx32, Cx36, Cx37, Cx40, Cx43, Cx45, Cx46, and Cx50. By using reverse transcriptase-polymerase chain reactions with primer oligonucleotides to murine genes, detected mRNAs Retinae from heterozygous mice targeted replacement most Cx45 open reading frame by a lacZ reporter gene showed promoter activity somata ganglion...

10.1002/1096-9861(20000918)425:2<193::aid-cne3>3.3.co;2-e article EN The Journal of Comparative Neurology 2000-09-18

Over the last few decades, a wealth of treatment options have become available for breast cancer. To specifically direct those therapies to patients with highest need who will receive greatest benefit, biomarkers are urgently needed. Two specific needs seem be most pressing: first is prognostic markers, which would determine group may recover without adjuvant chemotherapy. Second, predictive markers treatments, such as different endocrine chemotherapies or targeted drugs, expected play major...

10.2217/17410541.2.4.339 article EN Personalized Medicine 2005-10-28

&lt;div&gt;Abstract&lt;p&gt;&lt;b&gt;Purpose:&lt;/b&gt; We have shown that DNA methylation of the PITX2 gene predicts risk distant recurrence in steroid hormone receptor-positive, node-negative breast cancer. Here, we present results from a multicenter study investigating whether and other candidate markers predict outcome node-positive, estrogen HER-2-negative cancer patients who received adjuvant anthracycline-based chemotherapy.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Experimental Design:&lt;/b&gt;...

10.1158/1078-0432.c.6516897 preprint EN 2023-03-31

&lt;div&gt;Abstract&lt;p&gt;&lt;b&gt;Purpose:&lt;/b&gt; We have shown that DNA methylation of the PITX2 gene predicts risk distant recurrence in steroid hormone receptor-positive, node-negative breast cancer. Here, we present results from a multicenter study investigating whether and other candidate markers predict outcome node-positive, estrogen HER-2-negative cancer patients who received adjuvant anthracycline-based chemotherapy.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Experimental Design:&lt;/b&gt;...

10.1158/1078-0432.c.6516897.v1 preprint EN 2023-03-31
Coming Soon ...